SERPINE1 and metabolic dysfunction-associated steatotic liver disease: In NAFLD, the coagulation cascade leads to thrombin production after being activated by the VWF and plasminogen activator inhibitor type I (PAI-1), which stimulate platelet hyperactivity mediated by the proteinase activated receptor 1–4 (PAR1–4) [183].